128
V. Fehring et al. / Journal of Organometallic Chemistry 621 (2001) 120–129
BH3·SMe2 (1 M or 10 M, 36.6 mmol) the main part of
the solvent was evaporated and the residue hydrolyzed
with a solution of NH4Cl and diluted with CH2Cl2. The
organic phase was washed with brine and water, dried
and evaporated to give the crude product.
3.1.21.2. Ph2P-(CH2)4-P(4-C6H4OCH3)2 (20c). Yield:
0.55 g (53%); H-NMR (CDCl3): 1.53 (br), 1.95 (br),
1
2.01 (br), 3.77, 6.85 (m), 7.28–7.34, 7.37–7.40; 13C-
NMR (CDCl3): 28.8 (d, J=37.2), 28.1 (d, J=12.4),
28.7 (d, J=9.5), 55.6, 114.5 (d, J=6.7), 128.7 (d,
J=13.4), 128.8, 133.1 (d, J=18.1), 134.4 (d, J=20.0),
139.2 (d, J=13.4), 160.5; 31P-NMR (CDCl3): −19.2,
−15.7.
3.1.20.1.
Ph2P(BH3)–(CH2)4–P(BH3)(3,5-Me2C6H3)2
(19b). Yield (crude): 6.7 g. The crude product was
boiled with ethanol (200 ml) for extraction. The filtrate
was cooled to r.t. affording the pure product 19b.
Yield: 1.4 g (12%); 1H-NMR (CDCl3): 0.5–1.4 (6H, br),
1.58 (4H, m), 2.15 (4H, m), 2.31 (12H), 7.08 (2H), 7.21
(4H, m), 7.43 (6H, m), 7.63 (4H, m); 13C-NMR
(CDCl3): 21.3, 24.7 (d, J=15.3), 25.4 (dd, J=37.2,
10.5), 128.8 (d, J=9.5), 129.1 (d, J=33.4), 129.6 (d,
J=9.5), 131.2 (d, J=2.9), 132.1 (d, J=8.6), 133.0 (d,
J=2.0), 138.4 (d, J=10.5); 31P-NMR (CDCl3): 14.9
(br), 15.8 (br).
3.1.21.3. Ph2P–(CH2)4–PCy2 (20d). Yield: 1.1 g (99%);
1H-NMR (CDCl3): 1.0–1.2, 1.27 (br), 1.36–1.50, 1.60–
1.70, 1.98 (m), 7.22–7.26, 7.31–7.36; 13C-NMR
(CDCl3): 20.0 (d, J=16.2), 25.5, 26.3, 26.3 (d, J=
17.2), 26.8 (d, J=11.4), 27.0 (dd, J=16.2, 12.4), 28.0
(d, J=7.6), 29.1 (dd, J=18.6, 11.9), 29.3 (d, J=14.3),
32.3 (d, J=12.4), 127.4 (d, J=11.4), 127.4, 131.7 (d,
J=18.1), 137.9 (d, J=13.4); 31P-NMR (CDCl3):
−15.9, −3.5.
3.1.20.2. Ph2P(BH3)–(CH2)4–P(BH3)(4-C6H4OCH3)2
(19c). Yield (crude): 6.6 g (84%). The crude product 19c
was used without purification. 31P-NMR (CDCl3): 12.9
(br), 16.1 (br).
3.1.22. [Rh(P–P%)(COD)]BF4 (21b, 21c, 21d and
[Rh(Cy2P–(CH2)4–PCy2)(COD)]BF4)
The complexes were prepared analogously to com-
pound 9 from Rh(COD)acac, the diphosphines P–P%
and HBF4 as previously reported.
3.1.20.3. Ph2P(BH3)-(CH2)4-P(BH3)Cy2 (19d). The
crude product was extracted with hot ethanol (500 ml).
The filtrate was cooled to 5°C giving 19d as a white
3.1.22.1. [Rh(Ph2P–(CH2)4–P(3,5-Me2C6H3)2(COD)]-
BF4 (21b). Yield: 73%; 1H-NMR (CDCl3): 1.63 (m),
2.14 (m), 2.30, 4.40 (d, J=32.7), 7.10 (br), 7.13 (br),
7.45–7.55; 13C-NMR (CDCl3): 21.9, 25.1 (d, J=16.2),
30.9 (d, J=16.2), 100.3 (dt, J=59.4, 8.3), 129.7 (d,
J=9.5), 131.2 (d, J=9.5), 131.8, 132.7 (d, J=15.3),
133.1 (d, J=16.2), 133.4, 133.5, 139.3 (d, J=9.5);
31P-NMR (CDCl3): 23.5 (dd, J=143.4, 38.9), 24.4 (dd,
144.6, 38.9).
1
solid. Yield: 1.5 g (21%); H-NMR (CDCl3): 1.22 (10H,
m), 1.48–1.82 (18H, m), 2.23 (2H, m), 7.41–7.51 (6H,
m), 7.63–7.70 (4H, m); 13C-NMR (CDCl3): 19.5 (d,
J=31.5), 25.6 (d, J=13.4), 25.7 (d, J=18.1), 26.0 (d,
4.8), 26.4, 27.1 (d, J=1.9), 27.2 (d, J=1.9), 27.3, 32.1
(d, J=32.4), 129.3 (d, J=9.5), 129.8 (d, J=55.3),
131.7 (d, J=2.9), 132.5 (d, J=8.6); 31P-NMR
(CDCl3): 16.0 (d, J=55.5), 25.0 (d, J=66.6).
3.1.22.2. [Rh(Ph2P–(CH2)4–P(4-C6H4OCH3)2)(COD)]-
BF4 (21c). Yield: 63%; 1H-NMR (CDCl3): 1.89 (d,
J=21.6), 2.10 (m), 2.45 (br), 2.62 (br), 2.73, 3.99 (m),
4.16, 4.70 (d, J=21.2), 7.31–7.36, 7.75–7.91; 13C-
NMR (CDCl3): 25.1, 26.0, 30.8, 31.8 (d, J=25.2), 32.4
(d, J=24.8), 56.0, 68.4, 100.6 (dt, J=46.7, 7.6), 115.4
(d, J=10.5), 123.4 (d, J=46.7), 129.7 (d, J=9.5),
131.8, 133.1 (d, J=42.0), 133.6 (d, J=10.5), 135.1 (d,
J=11.4), 162.3; 31P-NMR (CDCl3): 22.1 (dd, J=
142.9, 40.2), 25.1 (dd, J=145.0, 39.5).
3.1.21. Ph2P–(CH2)4–PR2 (20b, 20c and 20d)
To a cool solution (−10°C) of the phosphinoborane
Ph2P(BH3)-(CH2)4-P(BH3)R2 (19) (2.15 mmol) in
CH2Cl2 (25 ml) was added HBF4·OEt2 (3 ml, 7.2 M,
21.5 mmol). The resulting solution was stirred over
night at r.t. Then ether was added until the solution
became turbid. The mixture was washed twice with a
solution of NaHCO3. The aqueous solutions were ex-
tracted with ether and the combined organic fractions
were washed with water and brine. The etheric solution
was dried and evaporated to give a slightly yellow oil,
which crystallized after a long time.
3.1.22.3. [Rh(Ph2P–(CH2)4–PCy2)(COD)]BF4 (21d).
Yield: 56%; 1H-NMR (CDCl3): 1.33 (br), 1.48 (br), 1.78
(m), 1.70–1.90, 2.01 (br), 2.27 (br), 2.24 (br), 2.50 (br),
3.67 (m), 3.95 (br), 5.03 (br), 7.5 (m), 7.6 (m); 13C-
NMR (CDCl3): 13.9 (d, J=25.7), 14.3, 21.5 (dd, J=
7.6, 2.9), 23.6, 24.6, 25.2, 25.9 (d, J=8.6), 26.4 (d,
J=12.4), 26.6 (d, J=24.8), 27.9 (d, J=2.9), 29.1, 30.2
(d, J=21.0), 36.3 (d, J=21.0), 64.8, 67.0, 96.0 (dt,
J=137.3, 8.1), 128.2 (d, J=9.5), 130.3 (d, J=1.9),
130.6 (d, J=42.0), 131.9 (d, J=10.5); 31P-NMR
3.1.21.1. Ph2P–(CH2)4–P(3,5-Me2C6H3)2 (20b). Yield:
1
1.0 g (96%); H-NMR (CDCl3): 1.47 (4H, m), 1.93 (4H,
m), 2.20 (12H), 6.86 (2H, m), 6.92 (2H, m), 6.94 (2H,
m), 7.23 (6H, m), 7.30 (4H, m); 13C-NMR (CDCl3):
20.4, 26.6 (m), 127.3 (d, J=13.4), 127.4, 129.2, 129.4
(d, J=13.4), 131.7 (d, J=18.1), 136.7 (d, J=6.7),
137.8 (d, J=13.4); 31P-NMR (CDCl3): −16.0, −15.8.